These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 19175850)

  • 1. A comparison of chronaxies for ventricular fibrillation induction, defibrillation, and cardiac stimulation: unexpected findings and their implications.
    Lawo T; Deneke T; Schrader J; Danilovic D; Wenzel B; Buddensiek M; Muegge A
    J Cardiovasc Electrophysiol; 2009 Mar; 20(3):307-14. PubMed ID: 19175850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting the transthoracic defibrillation shock directional vector based on VF amplitude improves shock success.
    Brooks L; Zhang Y; Dendi R; Anderson RH; Zimmerman B; Kerber RE
    J Cardiovasc Electrophysiol; 2009 Sep; 20(9):1032-8. PubMed ID: 19460079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quadriphasic waveforms are superior to triphasic waveforms for transthoracic defibrillation in a cardiac arrest swine model with high impedance.
    Zhang Y; Rhee B; Davies LR; Zimmerman MB; Snyder D; Jones JL; Kerber RE
    Resuscitation; 2006 Feb; 68(2):251-8. PubMed ID: 16325983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of defibrillation shocks for resuscitation of rapid ventricular tachycardia: does it make a difference?
    Turner I; Turner S; Grace AA
    Resuscitation; 2009 Feb; 80(2):183-8. PubMed ID: 19091453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical open-chest ventricular defibrillation: triphasic waveforms are superior to biphasic waveforms.
    Zhang Y; Boddicker KA; Davies LR; Jones JL; Kerber RE
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):941-8. PubMed ID: 15271014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Termination of ventricular tachycardia by far-field stimulation in humans: a feasibility study.
    Lawo T; Schrader J; Buddensiek M; Schweika O; Mügge A; Bösche LI
    Pacing Clin Electrophysiol; 2010 Dec; 33(12):1540-7. PubMed ID: 21039638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronaxie of defibrillation: a pathway toward further optimization of defibrillation waveform?
    Efimov IR
    J Cardiovasc Electrophysiol; 2009 Mar; 20(3):315-7. PubMed ID: 19175836
    [No Abstract]   [Full Text] [Related]  

  • 9. A model of ischemically induced ventricular fibrillation for comparison of fixed-dose and escalating-dose defibrillation strategies.
    Niemann JT; Rosborough JP; Walker RG
    Acad Emerg Med; 2004 Jun; 11(6):619-24. PubMed ID: 15175198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of induction method on defibrillation threshold and ventricular fibrillation cycle length.
    Zima E; Gergely M; Soós P; Gellér LA; Nemes A; Acsády G; Merkely B
    J Cardiovasc Electrophysiol; 2006 Apr; 17(4):377-81. PubMed ID: 16643358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving sufficient safety margins with fixed duration waveforms and the use of multiple time constants.
    Keane D; Aweh N; Hynes B; Sheahan RG; Cripps T; Bashir Y; Zaidi A; Fahy G; Lowe M; Doherty P; Kroll MK
    Pacing Clin Electrophysiol; 2007 May; 30(5):596-602. PubMed ID: 17461867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of drive cycle length on initiation of ventricular fibrillation during implantable cardioverter defibrillator threshold testing.
    Sanghvi NK; Lelorier P; Gururaj AV; Monahan KM
    Pacing Clin Electrophysiol; 2006 Sep; 29(9):926-9. PubMed ID: 16981914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dilemma of ICD implant testing.
    Swerdlow CD; Russo AM; Degroot PJ
    Pacing Clin Electrophysiol; 2007 May; 30(5):675-700. PubMed ID: 17461879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of transthoracic ventricular defibrillation-biphasic and triphasic shocks, waveform rounding, and synchronized shock delivery.
    Kidwai BJ; McIntyre A; Anderson J; Adgey AA
    J Electrocardiol; 2002 Jul; 35(3):235-44. PubMed ID: 12122614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
    Kirilmaz A; Dokumaci B; Uzun M; Kilicaslan F; Dinckal MH; Yucel O; Karaca M
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):498-505. PubMed ID: 15955181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation.
    Ayers GM; Alferness CA; Ilina M; Wagner DO; Sirokman WA; Adams JM; Griffin JC
    Circulation; 1994 Jan; 89(1):413-22. PubMed ID: 8281677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hyperbolic strength-duration relationship of defibrillation threshold.
    Irnich W
    IEEE Trans Biomed Eng; 2008 Aug; 55(8):2057-63. PubMed ID: 18632368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
    Albert CM; Rosenthal L; Calkins H; Steinberg JS; Ruskin JN; Wang P; Muller JE; Mittleman MA;
    J Am Coll Cardiol; 2007 Dec; 50(23):2233-40. PubMed ID: 18061071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of defibrillation efficacy with preshock synchronized pacing.
    Pak HN; Okuyama Y; Oh YS; Hayashi H; Liu YB; Chen PS; Lin SF
    J Cardiovasc Electrophysiol; 2004 May; 15(5):581-7. PubMed ID: 15149429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.